Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2021, Vol. 15 Issue (6) : 942-942    https://doi.org/10.1007/s11684-021-0876-z
ERRATUM
Midline2 is overexpressed and a prognostic indicator in human breast cancer and promotes breast cancer cell proliferation in vitro and in vivo
Lan Wang1, Jueheng Wu3, Jie Yuan3, Xun Zhu2,3, Hongmei Wu1, Mengfeng Li2,3()
1. Department of Microbiology and Immunology, School of Basic Courses, Guangdong Pharmaceutical University, Guangzhou 510006, China
2. Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China
3. Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou 510080, China
 Download: PDF(228 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Corresponding Author(s): Mengfeng Li   
Online First Date: 22 July 2021    Issue Date: 27 December 2021
 Cite this article:   
Lan Wang,Jueheng Wu,Jie Yuan, et al. Midline2 is overexpressed and a prognostic indicator in human breast cancer and promotes breast cancer cell proliferation in vitro and in vivo[J]. Front. Med., 2021, 15(6): 942-942.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-021-0876-z
https://academic.hep.com.cn/fmd/EN/Y2021/V15/I6/942
Fig.1  
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed